WHO Trial Registration Data Set (TRDS) Extension for Traditional Chinese Medicine 2020: Recommendations, Explanation, and Elaboration
Background: Although the WHO Trial Registration Data Set (TRDS) has been published for many years, the quality of clinical trial registrations with traditional Chinese medicine (TCM) is still not satisfactory, especially about the inadequate reporting on TCM interventions. The development of the WHO TRDS for TCM Extension 2020 (WHO TRDS-TCM 2020) aims to address this inadequacy.
Methods: A group of clinical experts, methodologists, epidemiologists, and editors has developed this WHO TRDS-TCM 2020 through a comprehensive process, including the baseline survey, draft of the initial items, three-round of Delphi survey, solicitation of comments, revision, and finalization.
Results: The WHO TRDS-TCM 2020 statement extends the latest version (V.1.3.1) of TRDS published in November 2017. The checklist includes 11 extended items (including subitems), namely Source(s) of Monetary or Material Support (Item 4), Scientific Title (Item 10a and 10b), Countries of Recruitment (Item 11), Health Condition(s) or Problem(s) Studied (Item 12), Intervention(s) (Item 13a, 13b and 13c), Key Inclusion and Exclusion Criteria (Item 14), Primary and Key Secondary Outcomes (Item 19 to 20), and Lay Summary (Item B1). For Item 13 (Interventions), three common TCM interventions--i.e., Chinese herbal medicine formulas, acupuncture and moxibustion—are elaborated.
Conclusions: The group hopes that the WHO TRDS-TCM 2020 can improve the reporting quality and transparency of TCM trial registrations, assist registries in assessing the registration quality of TCM trials, and help readers understand TCM trial design.
Trial registration: Not applicable.
This is a list of supplementary files associated with this preprint. Click to download.
Posted 02 Jul, 2020
On 17 Jul, 2020
On 08 Jul, 2020
On 30 Jun, 2020
On 29 Jun, 2020
On 29 Jun, 2020
On 29 Jun, 2020
On 29 Jun, 2020
On 24 Jun, 2020
Received 24 Jun, 2020
On 24 Jun, 2020
Invitations sent on 24 Jun, 2020
On 22 Jun, 2020
On 21 Jun, 2020
On 21 Jun, 2020
On 12 Jun, 2020
Received 02 Jun, 2020
On 25 Mar, 2020
Received 16 Mar, 2020
On 02 Mar, 2020
Invitations sent on 17 Feb, 2020
On 23 Jan, 2020
On 22 Jan, 2020
On 22 Jan, 2020
WHO Trial Registration Data Set (TRDS) Extension for Traditional Chinese Medicine 2020: Recommendations, Explanation, and Elaboration
Posted 02 Jul, 2020
On 17 Jul, 2020
On 08 Jul, 2020
On 30 Jun, 2020
On 29 Jun, 2020
On 29 Jun, 2020
On 29 Jun, 2020
On 29 Jun, 2020
On 24 Jun, 2020
Received 24 Jun, 2020
On 24 Jun, 2020
Invitations sent on 24 Jun, 2020
On 22 Jun, 2020
On 21 Jun, 2020
On 21 Jun, 2020
On 12 Jun, 2020
Received 02 Jun, 2020
On 25 Mar, 2020
Received 16 Mar, 2020
On 02 Mar, 2020
Invitations sent on 17 Feb, 2020
On 23 Jan, 2020
On 22 Jan, 2020
On 22 Jan, 2020
Background: Although the WHO Trial Registration Data Set (TRDS) has been published for many years, the quality of clinical trial registrations with traditional Chinese medicine (TCM) is still not satisfactory, especially about the inadequate reporting on TCM interventions. The development of the WHO TRDS for TCM Extension 2020 (WHO TRDS-TCM 2020) aims to address this inadequacy.
Methods: A group of clinical experts, methodologists, epidemiologists, and editors has developed this WHO TRDS-TCM 2020 through a comprehensive process, including the baseline survey, draft of the initial items, three-round of Delphi survey, solicitation of comments, revision, and finalization.
Results: The WHO TRDS-TCM 2020 statement extends the latest version (V.1.3.1) of TRDS published in November 2017. The checklist includes 11 extended items (including subitems), namely Source(s) of Monetary or Material Support (Item 4), Scientific Title (Item 10a and 10b), Countries of Recruitment (Item 11), Health Condition(s) or Problem(s) Studied (Item 12), Intervention(s) (Item 13a, 13b and 13c), Key Inclusion and Exclusion Criteria (Item 14), Primary and Key Secondary Outcomes (Item 19 to 20), and Lay Summary (Item B1). For Item 13 (Interventions), three common TCM interventions--i.e., Chinese herbal medicine formulas, acupuncture and moxibustion—are elaborated.
Conclusions: The group hopes that the WHO TRDS-TCM 2020 can improve the reporting quality and transparency of TCM trial registrations, assist registries in assessing the registration quality of TCM trials, and help readers understand TCM trial design.
Trial registration: Not applicable.